About Jason Rifkin
Jason Rifkin is a board member at Episteme Prognostics.
Jason Rifkin first appears on SEC filings in 2023.
Experience
This experience comes from Jason Rifkin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jason Rifkin in the role, so the role may have started earlier or lasted longer.
Episteme Prognostics, Inc. Current
Board Member
2021 – Present · Brooklyn, NY
Develops tests to help clinicians predict cancer patients' responses to chemotherapy.
SY
Syncromune® Current
Executive Vice President Business Development
2020 – Present
WN
West Harlem Innovation Network
Co-Head Life Sciences – Social Impact
2018 – 2021
SC
Spring Mountain Capital
Strategic Advisory Board Member
2018 – 2021
PI
PhageNova Bio., Inc
President and CEO
2015 – 2021
MI
MAX BioPharma, Inc.
Business Development Advisor
2014 – 2021
AZ
AZTherapies
Business Development Advisor
2015 – 2017
CU
Curaleaf
Executive Vice President
2014
CI
Cage Pharma, Inc.
President
2013
DS
Delcath Systems
Senior Vice President Commercial Programs
2007 – 2012
FR
Fox Rothschild
Associate – Corporate Department, Pharmaceuticals and Biotechnology Group
2006 – 2007
GW
Goldstein and Weinstein
Associate
2004 – 2006
TS
The Legal Aid Society
Associate
2003 – 2004
Key Colleagues at Startups
The people Jason Rifkin works with at each company, as listed on that company's latest Form D.
Episteme Prognostics, Inc. · Form D, Sep 4, 2026
RW
Robert Warren
Director
Surajit Dhara
Co-Founder, President, CEO, Board Member
GH
Gregory Ho
Board Member